- 31 March 2020
- journal article
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableFunding Information
- Uniwersytet Medyczny w Lodzi (503/1-152-01/503-11-002.)
This publication has 33 references indexed in Scilit:
- JAK inhibitors in dermatology: The promise of a new drug classJournal of the American Academy of Dermatology, 2017
- JAKs and STATs in Immunity, Immunodeficiency, and CancerNew England Journal of Medicine, 2013
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated DiseaseImmunity, 2012
- Potential role of interleukin-17 in the pathogenesis of bullous pemphigoidMedical Hypotheses, 2010
- Lesional Th17 cells in pemphigus vulgaris and pemphigus foliaceusJournal of Dermatological Science, 2009
- Selectivity and therapeutic inhibition of kinases: to be or not to be?Nature Immunology, 2009
- Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapyCytokine, 2008
- A Perspective of Pemphigus from Bedside and Laboratory-BenchClinical Reviews in Allergy & Immunology, 2007
- Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancerBritish Journal of Cancer, 2007
- Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active diseaseClinical and Experimental Dermatology, 2005